Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Bladder Cancer

Clinical Trial at: Texas Oncology - Wichita Falls

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Wichita Falls

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Texas Oncology - Wichita Falls

INCB 39110-209, An Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis

  • Details

ClinicalTrials.gov ID: NCT03144687
Diagnosis Type: NA
USOR Number: 17085

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Wichita Falls

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

5400 Kell West Blvd
Wichita Falls, Texas 76310
274.39 mi. away
P: (940) 691-8271

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Denton

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG®)Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Myelomas

Clinical Trial at: Texas Oncology - Denton

(Amgen 20180015) A Randomized, Open-label, Phase 3 Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination with Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (A.R.R.O.W.2).

  • Details

ClinicalTrials.gov ID: NCT03859427
Diagnosis Type: NA
USOR Number: 19036

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Denton

Phase 3 Study of Sacituzumab Govitecan (IMMU-132) Versus Treatment of Physician's Choice (TPC) in subjects with Hormonal Receptor-Positive (HR+) Human Epidermal Growth Factor Receptor 2 (HER2) Negative Metastatic Breast Cancer (MBC) who have failed at least two prior chemotherapy regimens (IMMU-132-09)

  • Details

ClinicalTrials.gov ID: NCT03901339
Diagnosis Type: NA
USOR Number: 18282

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Texas Oncology - Denton

ROMAN: Reduction in Oral Mucositis with Avasopasem Manganese (GC4419)- Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer (GTI-4419-301)

  • Details

ClinicalTrials.gov ID: NCT03689712
Diagnosis Type: NA
USOR Number: 18182

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Denton

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Denton

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Denton

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: NA
USOR Number: 19054

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Denton

(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)

  • Details

ClinicalTrials.gov ID: NCT03390504
Diagnosis Type: NA
USOR Number: 17133

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Texas Oncology - Denton

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Solid Tumors

Clinical Trial at: Texas Oncology - Denton

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: NA
USOR Number: 19079

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Denton

516-005: A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy in Combination with Checkpoint Inhibitor Therapy - SAPPHIRE Study

  • Details

ClinicalTrials.gov ID: NCT03906071
Diagnosis Type: NA
USOR Number: 19018

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Denton

A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + Platinum Chemotherapy with or without Pembrolizumab (MK-3475) in TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Participants (KEYNOTE-789; MK-3475-789)

  • Details

ClinicalTrials.gov ID: NCT03515837
Diagnosis Type: NA
USOR Number: 19020

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Denton

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Denton

(C3441020) A PHASE 2, NON-RANDOMIZED, OPEN LABEL, SINGLE ARM, MULTI-CENTER STUDY OF TALAZOPARIB FOR NEOADJUVANT TREATMENT OF GERMLINE BRCA1/2 MUTATION PATIENTS WITH EARLY HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE BREAST CANCER

  • Details

ClinicalTrials.gov ID: NCT03499353
Diagnosis Type: NA
USOR Number: 18042

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Denton

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Denton

SYD985.002: A multi-centre, open-label, randomized clinical trial comparing the efficacy and safety of the antibody-drug conjugate SYD985 to physician's choice in patients with HER2-positive unresectable locally advanced or metastatic breast cancer

  • Details

ClinicalTrials.gov ID: NCT03262935
Diagnosis Type: NA
USOR Number: 17027

  • Practice Details

3720 South I-35 East
Denton, Texas 76210
281.47 mi. away
P: (940) 382-1022

More Details View Practice Page

Pages